Composition for treating colorectal cancer and use for preparing medicine for treating colorectal cancer

Abstract

The invention discloses a composition treating colorectal cancer and applications of medicines treating colorectal cancer. The composition comprises the following ingredients containing treatment effective doses: any one or two of ground beetle and gekko swinhonis seu japonicus, any one or two of peach seeds and curcuma rhizome, any one or two of radix sophorae flavescentis and patrinia herb, any one or two of smilax glabra and cortex moutan, any one or two of garden burnet and barbat skullcap, any one or two of sophora flowers and pseudobulubs cremastrae seu pleiones, and any one or two of dandelion and manyleaf paris rhizome. The composition is provided in an ingredient ratio less than a poisonous dose. The composition also can comprise coix seeds or radix scrophulariae, and is used combined with chemotherapeutants further. The composition is suitable for colorectal cancer patients with current known various symptoms, can inhibit precancerous lesions effectively, improves mucous bloody stool of intestinal cancer patients, relieves radiation enteritis, raises life quality of intestinal cancer patients and provides a forward life expectancy with definite and objective therapeutic effects for intestinal cancer patients.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a composition for preventing, improving and treating disease states including colorectal cancer, preventing recurrence and / or metastasis after recovery, and improving the quality of life after recovery, and its preparation for treating colorectal cancer Use of cancer drugs. Background technique [0002] Colorectal cancer is one of the most common malignant tumors in clinical practice. Colorectal cancer includes colon cancer and rectal cancer, and it is the third most common malignant tumor in my country. The incidence of colorectal cancer is on the rise with the improvement of living standards. Worldwide, colorectal cancer ranks third in the incidence of common malignant tumors with 1,023,152 new cases per year, accounting for 10.38% of the total incidence of malignant tumors. The incidence of colorectal cancer in the United States rose from 99,000 cases in 1974 to 130,000 cases in 1984,...

AI Technical Summary

Problems solved by technology

But as far as the current situation is concerned, the anti-tumor research direction of traditional Chinese medicine is mainly concentrated on the treatment of Western medicine, and Chinese medicine is combined with radiotherapy and chemotherapy to reduce its toxic and side effects. Research from the perspective of inhibiting precancerous lesions, stabilizing tumor size, and prolonging patient survival

At the same time, there is a lack of prospective controlled studies on the treatment of colorectal cancer with integrated traditional Chinese and Western medicine, and the results of the studies are not convincing.

In addition, there are not many collaborative researches conducted by various units and centers, the standards of diagnosis and treatment are not uniform enough, and the samples of clinical observation cases are relatively small, lacking statistical significance

Some studies did not set up a strict control group, and the research results lacked evidence-based medical evidence, which seriously affected the promotion of traditional Chinese medicine in tumor treatment

Images